370 articles
Phase 1b trial tests escalating doses of experimental Alzheimer's treatment BMS-984923 for safety and tolerability in older adults.
24-week trial tested fucoxanthin-rich microalgae supplement on memory, attention, and executive function in 66 healthy seniors.
New study reveals how structured exercise enhances neuroprotective hormones and cognitive capacity in just 12 weeks.
Cornell study tests whether N-acetylcysteine can restore protective antioxidants in Parkinson's patients' brains using advanced brain imaging.
Vestibular rehabilitation program tested in dementia patients to reduce falls and improve balance through targeted inner ear training.
Study tests VR therapy versus traditional cognitive training in 60 patients with mild cognitive impairment and Alzheimer's disease.
Large 503-patient study tested whether Actovegin could improve thinking and memory problems that persist after stroke recovery.
NGP 555 targets toxic brain protein production in healthy volunteers, offering potential early intervention for Alzheimer's prevention.
409-person study shows tailored diet, exercise, and cognitive guidelines effectively improve brain health markers and reduce dementia risk.
Clinical trial compares gabapentin to estrogen therapy for treating menopausal hot flashes in 60 women over two years.
Mayo Clinic study reveals how early estrogen treatment affects brain blood flow and cognitive aging in postmenopausal women.
Study investigates why cholesterol-regulating protein PCSK9 responds differently to hormones in men versus women.
